Annual Accounts Receivable
$80.15 M
+$80.15 M+100.00%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual accounts receivable is $80.15 million, with the most recent change of +$80.15 million (+100.00%) on December 31, 2023.
- During the last 3 years, VYGR annual accounts receivable has risen by +$72.14 million (+900.37%).
- VYGR annual accounts receivable is now at all-time high.
Performance
VYGR Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$15.95 M
+$14.25 M+837.37%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly accounts receivable is $15.95 million, with the most recent change of +$14.25 million (+837.37%) on September 30, 2024.
- Over the past year, VYGR quarterly accounts receivable has dropped by -$64.20 million (-80.09%).
- VYGR quarterly accounts receivable is now -80.09% below its all-time high of $80.15 million, reached on December 31, 2023.
Performance
VYGR Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
VYGR Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -80.1% |
| 3 y3 years | +900.4% | +100.0% |
| 5 y5 years | +100.0% | +100.0% |
VYGR Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -80.1% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -80.1% | -100.0% |
| alltime | all time | at high | -100.0% | -80.1% | -100.0% |
Voyager Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.95 M(+837.4%) |
| Jun 2024 | - | $1.70 M(+103.3%) |
| Mar 2024 | - | $837.00 K(-99.0%) |
| Dec 2023 | $80.15 M(>+9900.0%) | $80.15 M(+220.6%) |
| Mar 2023 | - | $25.00 M(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $10.00 M(-14.8%) |
| Dec 2021 | $732.00 K(-90.9%) | - |
| Dec 2020 | $8.01 M(-56.7%) | - |
| Dec 2019 | $18.50 M(>+9900.0%) | - |
| Sep 2019 | - | $11.73 M(+42.4%) |
| Jun 2019 | - | $8.24 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Voyager Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Voyager Therapeutics?
- What is Voyager Therapeutics annual accounts receivable year-on-year change?
- What is Voyager Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly accounts receivable year-on-year change?
What is Voyager Therapeutics annual accounts receivable?
The current annual accounts receivable of VYGR is $80.15 M
What is the all time high annual accounts receivable for Voyager Therapeutics?
Voyager Therapeutics all-time high annual accounts receivable is $80.15 M
What is Voyager Therapeutics annual accounts receivable year-on-year change?
Over the past year, VYGR annual accounts receivable has changed by +$80.15 M (+100.00%)
What is Voyager Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of VYGR is $15.95 M
What is the all time high quarterly accounts receivable for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly accounts receivable is $80.15 M
What is Voyager Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, VYGR quarterly accounts receivable has changed by -$64.20 M (-80.09%)